Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse
Authors
Keywords
-
Journal
Blood Cancer Journal
Volume 11, Issue 6, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-16
DOI
10.1038/s41408-021-00506-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
- (2021) Sara Harrysson et al. Blood Cancer Journal
- Integration of COO into the clinical CNS International Prognostic Index could improve CNS relapse prediction in DLBCL
- (2019) Magdalena Klanova et al. BLOOD
- Addition of high-dose methotrexate to standard treatment for patients with high-risk diffuse large B-cell lymphoma contributes to improved freedom from progression and survival but does not prevent central nervous system relapse
- (2019) Neta Goldschmidt et al. LEUKEMIA & LYMPHOMA
- Systemic HD-MTX for CNS prophylaxis in high-risk DLBCL patients: a prospectively collected, single-center cohort analysis
- (2019) Kyoungmin Lee et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Stand-alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R-CHOP and is associated increased infection-related toxicity
- (2019) Toby A. Eyre et al. BRITISH JOURNAL OF HAEMATOLOGY
- Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma
- (2018) Tarec Christoffer El-Galaly et al. EUROPEAN JOURNAL OF CANCER
- Primary breast diffuse large B-cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure
- (2018) Shaoxuan Hu et al. CANCER SCIENCE
- Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era
- (2016) Robert Kridel et al. BRITISH JOURNAL OF HAEMATOLOGY
- CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP
- (2016) Norbert Schmitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis
- (2014) A. M. Petrich et al. BLOOD
- A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma
- (2014) C Y Cheah et al. BRITISH JOURNAL OF CANCER
- A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era
- (2014) Peter J. Hosein et al. BRITISH JOURNAL OF HAEMATOLOGY
- Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era
- (2014) Andrés J. M. Ferreri et al. BRITISH JOURNAL OF HAEMATOLOGY
- Double hit lymphoma: the MD Anderson Cancer Center clinical experience
- (2014) Yasuhiro Oki et al. BRITISH JOURNAL OF HAEMATOLOGY
- CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group
- (2011) N. Schmitz et al. ANNALS OF ONCOLOGY
- Lack of benefit of central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era
- (2011) Anita Kumar et al. CANCER
- First-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma With Rituximab-CHOP, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an International Phase II Trial
- (2011) Umberto Vitolo et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now